Approval · Notice of Compliance 3162 · 1998
APO-VALPROIC: Notice of Compliance 3162
Issued July 14, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3162
- Date
- July 14, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Therapeutic class
- Anticonvulsant
- Canadian reference product
- DEPAKENE SYRUP (Abbott Laboratories Co.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-VALPROIC | 02238370 | Dormant |
Medicinal ingredients
- VALPROIC ACID 50 MG per ML